About
R&D
Approach
Therapeutic areas
Scientific publications
R&D centers
Scientific and medical board
Scientific partnerships
Pipeline
Overview
TOTUM•63
Lipidrive® (TOTUM•070)
TOTUM•854
TOTUM•448
Manufacturing
Investors
Presentation
Shareholder space
Financial Information
Breakdown of Share Capital
Financial Calendar
Regulatory information
Annual General Meeting
Newsroom
News
Releases
Media resources
FR
EN
J.P. Morgan Healthcare Conference / H.C. Wainwright BioConnect Conference
Page d'accueil
>
J.P. Morgan Healthcare Conference / H.C. Wainwright BioConnect Conference
Valbiotis participates in the 39th J.P. Morgan Healthcare annual conference as well as in H.C. Wainwright BioConnect from January 11-14, 2021, in virtual format.
